Home / TATVA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TATVA.NS make money? Does TATVA.NS have pricing power? What's the Earnings Whisper? Will TATVA.NS profit more as the business scales? What is TATVA.NS's management track record? Is TATVA.NS's current price justified?

Tatva Chintan Pharma Chem Limited

₹1944 +$619.30 (+46.75%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹1940.7

Day Range

₹1900₹1973.4

Year Range

₹1044.1₹2008.7

Market Cap

45.47B

AVG Volume

130.25K

Trailing/Forward PE

88.48/41.06

PEG ratio

1.45

Dividend Yield

0.10%

Next Earnings Date

2026-10-19

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

TATVA.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	5.56B
26 Q4	5.06B
26 Q3	4.8B
26 Q2	4.34B
26 Q1	3.94B
25 Q4	3.83B
25 Q3	3.73B
25 Q2	3.71B
25 Q1	3.85B
24 Q4	3.94B

Net Income (INR) · TTM

TATVA.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	513.84M
26 Q4	420.54M
26 Q3	327.63M
26 Q2	177.36M
26 Q1	71.55M
25 Q4	57.13M
25 Q3	142.97M
25 Q2	176.14M
25 Q1	260.59M
24 Q4	303.54M

Operating Income (INR) · TTM

TATVA.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	696.82M
26 Q4	563.11M
26 Q3	740.69M
26 Q2	887.78M
26 Q1	743.9M
25 Q4	719.81M
25 Q3	599.68M
25 Q2	332.53M
25 Q1	797.65M
24 Q4	1.19B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Tatva Chintan Pharma Chem Limited

Video analysis: TATVA.NS

News: TATVA.NS

Similar companies